Coronary artery disease is a predictor of progression to dialysis in patients with chronic kidney disease, type 2 diabetes mellitus, and anemia: An analysis of the trial to reduce cardiovascular events with aranesp therapy (TREAT)

Marwa A. Sabe*, Brian Claggett, Emmanuel A. Burdmann, Akshay S. Desai, Peter Ivanovich, Reshma Kewalramani, Eldrin F. Lewis, John J.V. McMurray, Kurt A. Olson, Patrick Parfrey, Scott D. Solomon, Marc A. Pfeffer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Coronary artery disease is a predictor of progression to dialysis in patients with chronic kidney disease, type 2 diabetes mellitus, and anemia: An analysis of the trial to reduce cardiovascular events with aranesp therapy (TREAT)'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS